Open Access Article
Helena R.
Moreira
ab,
Rosanne M.
Raftery
cde,
Lucília P.
da Silva
ab,
Mariana T.
Cerqueira
ab,
Rui L.
Reis
ab,
Alexandra P.
Marques
ab and
Fergal J.
O'Brien
*cde
a3B's Research Group, I3Bs – Research Institute on Biomaterials, Biodegradables and Biomimetics, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, University of Minho, Avepark, Barco, 4805-017 Guimarães, Portugal
bICVS/3B's – PT Government Associate Laboratory, Braga/Guimarães 4805-017, Portugal
cTissue Engineering Research Group, Dept. of Anatomy & Regenerative Medicine, Royal College of Surgeons in Ireland (RCSI), Dublin, Ireland. E-mail: fjobrien@rcsi.ie
dTrinity Centre for Biomedical Engineering, Trinity College Dublin (TCD), Dublin, Ireland
eAdvanced Materials and Bioengineering Research (AMBER) Centre, RCSI & TCD, Dublin, Ireland
First published on 29th January 2021
Correction for ‘In vitro vascularization of tissue engineered constructs by non-viral delivery of pro-angiogenic genes’ by Helena R. Moreira et al., Biomater. Sci., 2021, DOI: 10.1039/d0bm01560a.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
| This journal is © The Royal Society of Chemistry 2021 |